Published in Arch Gen Psychiatry on August 01, 2005
Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet (2006) 2.53
A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron (2011) 1.92
Epigenetic regulation in human brain-focus on histone lysine methylation. Biol Psychiatry (2008) 1.48
Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection. Schizophr Res (2007) 1.25
Epigenetics of major psychosis: progress, problems and perspectives. Trends Genet (2012) 1.24
Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev (2009) 1.17
Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta (2009) 1.17
Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology (2011) 1.17
Balancing histone methylation activities in psychiatric disorders. Trends Mol Med (2011) 1.14
Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis. J Neural Transm (Vienna) (2008) 1.10
Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci (2009) 0.99
Epigenetic approaches to psychiatric disorders. Dialogues Clin Neurosci (2010) 0.99
Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry (2011) 0.97
Mitochondrial DNA: A Blind Spot in Neuroepigenetics. Biomol Concepts (2012) 0.95
Regulation of histone H3K4 methylation in brain development and disease. Philos Trans R Soc Lond B Biol Sci (2014) 0.94
How the epigenome contributes to the development of psychiatric disorders. Dev Psychobiol (2010) 0.92
Lysine metabolism in mammalian brain: an update on the importance of recent discoveries. Amino Acids (2013) 0.90
Early origins of adult disease: approaches for investigating the programmable epigenome in humans, nonhuman primates, and rodents. ILAR J (2012) 0.89
The molecular pathology of schizophrenia--focus on histone and DNA modifications. Brain Res Bull (2009) 0.89
Prefrontal cortical dysfunction after overexpression of histone deacetylase 1. Biol Psychiatry (2013) 0.89
DNA methylation in schizophrenia: progress and challenges of epigenetic studies. Genome Med (2012) 0.89
Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide. J Psychiatr Res (2012) 0.87
Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors. Eur Arch Psychiatry Clin Neurosci (2013) 0.87
Schizophrenia proteomics: biomarkers on the path to laboratory medicine? Diagn Pathol (2006) 0.85
The HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats. Front Psychiatry (2011) 0.85
Suicide and the polyamine system. CNS Neurol Disord Drug Targets (2013) 0.82
Histone H3 phosphorylation is upregulated in PBMCs of schizophrenia patients in comparison to healthy controls. Schizophr Res (2015) 0.79
Epigenetic management of major psychosis. Clin Epigenetics (2011) 0.79
Understanding the genetic liability to schizophrenia through the neuroepigenome. Schizophr Res (2016) 0.79
Horizons of psychiatric genetics and epigenetics: where are we and where are we heading? Iran J Psychiatry Behav Sci (2014) 0.78
From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia. Front Neurosci (2016) 0.77
Role of Epigenetics in Biology and Human Diseases. Iran Biomed J (2016) 0.75
Rethinking the Epigenetic Framework to Unravel the Molecular Pathology of Schizophrenia. Int J Mol Sci (2017) 0.75
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res (2005) 17.58
Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell (2007) 8.99
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Genome-wide association and meta-analysis of bipolar disorder in individuals of European ancestry. Proc Natl Acad Sci U S A (2009) 3.49
DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat Neurosci (2010) 3.47
Prevalence and test characteristics of national health safety network ventilator-associated events. Crit Care Med (2014) 3.46
Human postmortem tissue: what quality markers matter? Brain Res (2006) 2.92
A proposal for a coordinated effort for the determination of brainwide neuroanatomical connectivity in model organisms at a mesoscopic scale. PLoS Comput Biol (2009) 2.88
Antidepressant effect of optogenetic stimulation of the medial prefrontal cortex. J Neurosci (2010) 2.84
Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry (2003) 2.82
Internet-enabled high-resolution brain mapping and virtual microscopy. Neuroimage (2007) 2.75
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
Gender-specific gene expression in post-mortem human brain: localization to sex chromosomes. Neuropsychopharmacology (2004) 2.48
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
Endocytosis and synaptic removal of NR3A-containing NMDA receptors by PACSIN1/syndapin1. Nat Neurosci (2006) 2.37
DNA replication origins fire stochastically in fission yeast. Mol Biol Cell (2005) 2.35
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Differences in resting-state functional magnetic resonance imaging functional network connectivity between schizophrenia and psychotic bipolar probands and their unaffected first-degree relatives. Biol Psychiatry (2012) 2.33
Conflict of interest. Am J Psychiatry (2006) 2.30
Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex. Biol Psychiatry (2009) 2.25
Towards effective and rewarding data sharing. Neuroinformatics (2003) 2.24
Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci (2007) 2.24
Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered synaptic vesicular transport in post-mortem cerebellum. PLoS One (2008) 2.22
Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. Am J Psychiatry (2008) 2.13
Switching of NMDA receptor 2A and 2B subunits at thalamic and cortical synapses during early postnatal development. J Neurosci (2004) 2.11
A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron (2011) 1.92
Serine 31 phosphorylation of histone variant H3.3 is specific to regions bordering centromeres in metaphase chromosomes. Proc Natl Acad Sci U S A (2005) 1.91
Development of hippocampal mossy fiber synaptic outputs by new neurons in the adult brain. Proc Natl Acad Sci U S A (2008) 1.90
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. Am J Psychiatry (2013) 1.85
Epigenetic signatures of autism: trimethylated H3K4 landscapes in prefrontal neurons. Arch Gen Psychiatry (2011) 1.81
Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS One (2009) 1.78
Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.76
Ammonia and carbon dioxide concentrations in disposable and reusable ventilated mouse cages. J Am Assoc Lab Anim Sci (2008) 1.75
Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry (2009) 1.71
Epigenetic regulation of RAC1 induces synaptic remodeling in stress disorders and depression. Nat Med (2013) 1.70
Cycling of NMDA receptors during trafficking in neurons before synapse formation. J Neurosci (2004) 1.64
Circadian patterns of gene expression in the human brain and disruption in major depressive disorder. Proc Natl Acad Sci U S A (2013) 1.63
Brain activity in adolescent major depressive disorder before and after fluoxetine treatment. Am J Psychiatry (2012) 1.61
AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry (2008) 1.60
Methodological considerations for gene expression profiling of human brain. J Neurosci Methods (2007) 1.59
Temporal and regional expression of NMDA receptor subunit NR3A in the mammalian brain. J Comp Neurol (2002) 1.57
Sample matching by inferred agonal stress in gene expression analyses of the brain. BMC Genomics (2007) 1.54
Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology (2006) 1.53
P50 sensory gating ratios in schizophrenics and controls: a review and data analysis. Psychiatry Res (2008) 1.52
Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia. Synapse (2011) 1.43
Gray matter volume as an intermediate phenotype for psychosis: Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry (2013) 1.43
Vesicular glutamate transporters define two sets of glutamatergic afferents to the somatosensory thalamus and two thalamocortical projections in the mouse. J Comp Neurol (2008) 1.42
DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol (2006) 1.42
Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr Res (2004) 1.41
Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia. Am J Psychiatry (2015) 1.40
Mitochondrial involvement in psychiatric disorders. Ann Med (2008) 1.38
Mitochondrial variants in schizophrenia, bipolar disorder, and major depressive disorder. PLoS One (2009) 1.36
SNPs on chips: the hidden genetic code in expression arrays. Biol Psychiatry (2006) 1.36
Diffusion tensor imaging white matter endophenotypes in patients with schizophrenia or psychotic bipolar disorder and their relatives. Am J Psychiatry (2013) 1.35
Is aberrant functional connectivity a psychosis endophenotype? A resting state functional magnetic resonance imaging study. Biol Psychiatry (2013) 1.31
Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. J Neurochem (2005) 1.27
Induction of activating transcription factors (ATFs) ATF2, ATF3, and ATF4 in the nucleus accumbens and their regulation of emotional behavior. J Neurosci (2008) 1.27
Genetics and intermediate phenotypes of the schizophrenia--bipolar disorder boundary. Neurosci Biobehav Rev (2009) 1.26
Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling. J Neurochem (2004) 1.25
The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell (2013) 1.23
CRY2 is associated with depression. PLoS One (2010) 1.23
Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiatry (2011) 1.22
Stereotyped axon pruning via plexin signaling is associated with synaptic complex elimination in the hippocampus. J Neurosci (2005) 1.21
Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex. J Psychiatr Res (2013) 1.20
Reimagining psychoses: an agnostic approach to diagnosis. Schizophr Res (2013) 1.20
Human CD4+ T cell epitopes from vaccinia virus induced by vaccination or infection. PLoS Pathog (2007) 1.20
Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry (2003) 1.19
Frontal lobe metabolic decreases with sleep deprivation not totally reversed by recovery sleep. Neuropsychopharmacology (2006) 1.19
Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull (2010) 1.19
Serum response factor promotes resilience to chronic social stress through the induction of DeltaFosB. J Neurosci (2010) 1.19
Insight and frontal cortical function in schizophrenia: a review. Schizophr Res (2006) 1.18
Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry (2002) 1.17
Disruption of IFT complex A causes cystic kidneys without mitotic spindle misorientation. J Am Soc Nephrol (2012) 1.16
Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res (2011) 1.16
Regional alterations in RGS4 protein in schizophrenia. Synapse (2006) 1.15
Basal ganglia pathology in schizophrenia: dopamine connections and anomalies. J Neurochem (2010) 1.14
Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biol Psychiatry (2009) 1.14
Hyperspectral imaging for early detection of oxygenation and perfusion changes in irradiated skin. J Biomed Opt (2012) 1.13
Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims. Int J Neuropsychopharmacol (2008) 1.12
MHC class I molecules are present both pre- and postsynaptically in the visual cortex during postnatal development and in adulthood. Proc Natl Acad Sci U S A (2010) 1.12
Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biol Psychiatry (2003) 1.11
Fine structural localization of connexin-36 immunoreactivity in mouse cerebral cortex and thalamus. J Comp Neurol (2003) 1.11